Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin bioequivalence study in patients with impaired renal function
2019-005021-79Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofloxacin in bacterial disease (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Drug exposure in the first 24 hours of treatment. Started Mar 2020; status: active.
02
Drugs
ciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2019-005021-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-005021-79.